nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—psoriatic arthritis—Crohn's disease	0.302	0.387	CtDrD
Prednisone—ankylosing spondylitis—Crohn's disease	0.249	0.319	CtDrD
Prednisone—ulcerative colitis—Crohn's disease	0.229	0.294	CtDrD
Prednisone—ALB—Crohn's disease	0.183	1	CbGaD
Prednisone—Nitrogen balance negative—Azathioprine—Crohn's disease	0.00265	0.104	CcSEcCtD
Prednisone—HSD11B1—smooth muscle tissue—Crohn's disease	0.00139	0.163	CbGeAlD
Prednisone—HSD11B1—skin of body—Crohn's disease	0.00137	0.16	CbGeAlD
Prednisone—HSD11B1—mammalian vulva—Crohn's disease	0.00125	0.146	CbGeAlD
Prednisone—Meningitis—Azathioprine—Crohn's disease	0.000858	0.0335	CcSEcCtD
Prednisone—ALB—gall bladder—Crohn's disease	0.000838	0.0981	CbGeAlD
Prednisone—Oesophageal ulcer—Mesalazine—Crohn's disease	0.00083	0.0325	CcSEcCtD
Prednisone—Pancreatitis acute—Mesalazine—Crohn's disease	0.000656	0.0257	CcSEcCtD
Prednisone—HSD11B1—lymph node—Crohn's disease	0.000626	0.0733	CbGeAlD
Prednisone—Ulcer—Mercaptopurine—Crohn's disease	0.00059	0.0231	CcSEcCtD
Prednisone—Hirsutism—Mesalazine—Crohn's disease	0.000521	0.0204	CcSEcCtD
Prednisone—Sepsis—Mercaptopurine—Crohn's disease	0.000484	0.0189	CcSEcCtD
Prednisone—HSD11B1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000447	0.153	CbGpPWpGaD
Prednisone—Dermatitis atopic—Mesalazine—Crohn's disease	0.000409	0.016	CcSEcCtD
Prednisone—Acne—Mesalazine—Crohn's disease	0.00036	0.0141	CcSEcCtD
Prednisone—Delirium—Mesalazine—Crohn's disease	0.000352	0.0138	CcSEcCtD
Prednisone—Amenorrhoea—Mesalazine—Crohn's disease	0.000345	0.0135	CcSEcCtD
Prednisone—Pancreatitis—Mercaptopurine—Crohn's disease	0.000343	0.0134	CcSEcCtD
Prednisone—Vasculitis—Azathioprine—Crohn's disease	0.000341	0.0133	CcSEcCtD
Prednisone—Arthropathy—Mesalazine—Crohn's disease	0.000333	0.013	CcSEcCtD
Prednisone—SLCO1A2—digestive system—Crohn's disease	0.000332	0.0388	CbGeAlD
Prednisone—Leukocytosis—Mesalazine—Crohn's disease	0.000322	0.0126	CcSEcCtD
Prednisone—Skin exfoliation—Mesalazine—Crohn's disease	0.000289	0.0113	CcSEcCtD
Prednisone—Neuropathy—Mesalazine—Crohn's disease	0.000284	0.0111	CcSEcCtD
Prednisone—Ecchymosis—Mesalazine—Crohn's disease	0.000274	0.0107	CcSEcCtD
Prednisone—NR3C1—epithelium—Crohn's disease	0.000273	0.0319	CbGeAlD
Prednisone—CYP2C19—digestive system—Crohn's disease	0.000266	0.0311	CbGeAlD
Prednisone—NR3C1—smooth muscle tissue—Crohn's disease	0.000263	0.0308	CbGeAlD
Prednisone—NR3C1—skin of body—Crohn's disease	0.000259	0.0304	CbGeAlD
Prednisone—Immune system disorder—Mercaptopurine—Crohn's disease	0.000253	0.0099	CcSEcCtD
Prednisone—Alopecia—Mercaptopurine—Crohn's disease	0.000248	0.00969	CcSEcCtD
Prednisone—Malnutrition—Mercaptopurine—Crohn's disease	0.000244	0.00954	CcSEcCtD
Prednisone—NR3C1—mammalian vulva—Crohn's disease	0.000237	0.0277	CbGeAlD
Prednisone—Increased appetite—Mesalazine—Crohn's disease	0.000234	0.00915	CcSEcCtD
Prednisone—Anaemia—Mercaptopurine—Crohn's disease	0.000226	0.00882	CcSEcCtD
Prednisone—Lethargy—Mesalazine—Crohn's disease	0.000224	0.00877	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00022	0.0086	CcSEcCtD
Prednisone—Osteoarthritis—Mesalazine—Crohn's disease	0.00022	0.0086	CcSEcCtD
Prednisone—Affect lability—Mesalazine—Crohn's disease	0.000216	0.00846	CcSEcCtD
Prednisone—Face oedema—Mesalazine—Crohn's disease	0.000212	0.0083	CcSEcCtD
Prednisone—NR3C1—lymphoid tissue—Crohn's disease	0.00021	0.0246	CbGeAlD
Prednisone—Mood swings—Mesalazine—Crohn's disease	0.000208	0.00815	CcSEcCtD
Prednisone—Arthralgia—Mercaptopurine—Crohn's disease	0.000208	0.00812	CcSEcCtD
Prednisone—NR3C1—digestive system—Crohn's disease	0.000208	0.0243	CbGeAlD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000206	0.00807	CcSEcCtD
Prednisone—Pancreatitis—Azathioprine—Crohn's disease	0.000205	0.008	CcSEcCtD
Prednisone—Dry skin—Mesalazine—Crohn's disease	0.000202	0.00788	CcSEcCtD
Prednisone—Oedema—Mercaptopurine—Crohn's disease	0.000199	0.00779	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000194	0.00758	CcSEcCtD
Prednisone—Skin disorder—Mercaptopurine—Crohn's disease	0.000193	0.00756	CcSEcCtD
Prednisone—Abdominal distension—Mesalazine—Crohn's disease	0.000191	0.00748	CcSEcCtD
Prednisone—Anorexia—Mercaptopurine—Crohn's disease	0.00019	0.00742	CcSEcCtD
Prednisone—ALB—lymph node—Crohn's disease	0.000188	0.022	CbGeAlD
Prednisone—Pancreatitis—Mesalazine—Crohn's disease	0.000186	0.00729	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000181	0.00709	CcSEcCtD
Prednisone—Neutropenia—Mesalazine—Crohn's disease	0.000178	0.00695	CcSEcCtD
Prednisone—Decreased appetite—Mercaptopurine—Crohn's disease	0.000173	0.00677	CcSEcCtD
Prednisone—Weight increased—Mesalazine—Crohn's disease	0.000173	0.00676	CcSEcCtD
Prednisone—Weight decreased—Mesalazine—Crohn's disease	0.000172	0.00672	CcSEcCtD
Prednisone—Depression—Mesalazine—Crohn's disease	0.000169	0.00661	CcSEcCtD
Prednisone—HSD11B1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.000169	0.0576	CbGpPWpGaD
Prednisone—Haemoglobin—Azathioprine—Crohn's disease	0.000168	0.00656	CcSEcCtD
Prednisone—Haemorrhage—Azathioprine—Crohn's disease	0.000167	0.00653	CcSEcCtD
Prednisone—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000166	0.0065	CcSEcCtD
Prednisone—Body temperature increased—Mercaptopurine—Crohn's disease	0.000157	0.00616	CcSEcCtD
Prednisone—CYP3A4—digestive system—Crohn's disease	0.000157	0.0184	CbGeAlD
Prednisone—Haemoglobin—Mesalazine—Crohn's disease	0.000153	0.00598	CcSEcCtD
Prednisone—Haemorrhage—Mesalazine—Crohn's disease	0.000152	0.00595	CcSEcCtD
Prednisone—Immune system disorder—Azathioprine—Crohn's disease	0.000151	0.0059	CcSEcCtD
Prednisone—Connective tissue disorder—Mesalazine—Crohn's disease	0.00015	0.00585	CcSEcCtD
Prednisone—Arrhythmia—Azathioprine—Crohn's disease	0.000149	0.00583	CcSEcCtD
Prednisone—Alopecia—Azathioprine—Crohn's disease	0.000148	0.00577	CcSEcCtD
Prednisone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000147	0.00574	CcSEcCtD
Prednisone—ABCB1—epithelium—Crohn's disease	0.000146	0.0171	CbGeAlD
Prednisone—Eye disorder—Mesalazine—Crohn's disease	0.000142	0.00556	CcSEcCtD
Prednisone—Angiopathy—Mesalazine—Crohn's disease	0.000138	0.0054	CcSEcCtD
Prednisone—Immune system disorder—Mesalazine—Crohn's disease	0.000137	0.00537	CcSEcCtD
Prednisone—Diarrhoea—Mercaptopurine—Crohn's disease	0.000136	0.00533	CcSEcCtD
Prednisone—Ill-defined disorder—Azathioprine—Crohn's disease	0.000135	0.00527	CcSEcCtD
Prednisone—Alopecia—Mesalazine—Crohn's disease	0.000134	0.00526	CcSEcCtD
Prednisone—Anaemia—Azathioprine—Crohn's disease	0.000134	0.00525	CcSEcCtD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.000134	0.0456	CbGpPWpGaD
Prednisone—Mental disorder—Mesalazine—Crohn's disease	0.000133	0.00521	CcSEcCtD
Prednisone—Erythema—Mesalazine—Crohn's disease	0.000132	0.00518	CcSEcCtD
Prednisone—Malaise—Azathioprine—Crohn's disease	0.000131	0.00513	CcSEcCtD
Prednisone—ABCB1—mammalian vulva—Crohn's disease	0.000127	0.0148	CbGeAlD
Prednisone—Vomiting—Mercaptopurine—Crohn's disease	0.000127	0.00495	CcSEcCtD
Prednisone—Rash—Mercaptopurine—Crohn's disease	0.000126	0.00491	CcSEcCtD
Prednisone—Dermatitis—Mercaptopurine—Crohn's disease	0.000125	0.00491	CcSEcCtD
Prednisone—Vision blurred—Mesalazine—Crohn's disease	0.000125	0.00488	CcSEcCtD
Prednisone—Arthralgia—Azathioprine—Crohn's disease	0.000124	0.00484	CcSEcCtD
Prednisone—Myalgia—Azathioprine—Crohn's disease	0.000124	0.00484	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000123	0.00481	CcSEcCtD
Prednisone—Ill-defined disorder—Mesalazine—Crohn's disease	0.000123	0.0048	CcSEcCtD
Prednisone—Anaemia—Mesalazine—Crohn's disease	0.000122	0.00479	CcSEcCtD
Prednisone—Discomfort—Azathioprine—Crohn's disease	0.000122	0.00478	CcSEcCtD
Prednisone—Angioedema—Mesalazine—Crohn's disease	0.000121	0.00473	CcSEcCtD
Prednisone—Malaise—Mesalazine—Crohn's disease	0.000119	0.00467	CcSEcCtD
Prednisone—Vertigo—Mesalazine—Crohn's disease	0.000119	0.00465	CcSEcCtD
Prednisone—Syncope—Mesalazine—Crohn's disease	0.000119	0.00464	CcSEcCtD
Prednisone—NR3C1—lymph node—Crohn's disease	0.000119	0.0139	CbGeAlD
Prednisone—Nausea—Mercaptopurine—Crohn's disease	0.000118	0.00463	CcSEcCtD
Prednisone—Infection—Azathioprine—Crohn's disease	0.000118	0.00461	CcSEcCtD
Prednisone—Loss of consciousness—Mesalazine—Crohn's disease	0.000116	0.00455	CcSEcCtD
Prednisone—Skin disorder—Azathioprine—Crohn's disease	0.000115	0.00451	CcSEcCtD
Prednisone—Hypertension—Mesalazine—Crohn's disease	0.000114	0.00447	CcSEcCtD
Prednisone—Arthralgia—Mesalazine—Crohn's disease	0.000113	0.00441	CcSEcCtD
Prednisone—Myalgia—Mesalazine—Crohn's disease	0.000113	0.00441	CcSEcCtD
Prednisone—ABCB1—lymphoid tissue—Crohn's disease	0.000112	0.0132	CbGeAlD
Prednisone—Anxiety—Mesalazine—Crohn's disease	0.000112	0.00439	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000112	0.00438	CcSEcCtD
Prednisone—Discomfort—Mesalazine—Crohn's disease	0.000111	0.00436	CcSEcCtD
Prednisone—ABCB1—digestive system—Crohn's disease	0.000111	0.013	CbGeAlD
Prednisone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000108	0.00423	CcSEcCtD
Prednisone—Anaphylactic shock—Mesalazine—Crohn's disease	0.000108	0.00423	CcSEcCtD
Prednisone—Oedema—Mesalazine—Crohn's disease	0.000108	0.00423	CcSEcCtD
Prednisone—Infection—Mesalazine—Crohn's disease	0.000107	0.0042	CcSEcCtD
Prednisone—Shock—Mesalazine—Crohn's disease	0.000106	0.00416	CcSEcCtD
Prednisone—Nervous system disorder—Mesalazine—Crohn's disease	0.000106	0.00414	CcSEcCtD
Prednisone—Tachycardia—Mesalazine—Crohn's disease	0.000105	0.00412	CcSEcCtD
Prednisone—Skin disorder—Mesalazine—Crohn's disease	0.000105	0.00411	CcSEcCtD
Prednisone—Hyperhidrosis—Mesalazine—Crohn's disease	0.000104	0.00409	CcSEcCtD
Prednisone—Anorexia—Mesalazine—Crohn's disease	0.000103	0.00403	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	9.85e-05	0.00385	CcSEcCtD
Prednisone—Feeling abnormal—Azathioprine—Crohn's disease	9.78e-05	0.00382	CcSEcCtD
Prednisone—Insomnia—Mesalazine—Crohn's disease	9.78e-05	0.00382	CcSEcCtD
Prednisone—Paraesthesia—Mesalazine—Crohn's disease	9.71e-05	0.00379	CcSEcCtD
Prednisone—Gastrointestinal pain—Azathioprine—Crohn's disease	9.7e-05	0.00379	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.61e-05	0.0328	CbGpPWpGaD
Prednisone—Dyspepsia—Mesalazine—Crohn's disease	9.51e-05	0.00372	CcSEcCtD
Prednisone—Decreased appetite—Mesalazine—Crohn's disease	9.4e-05	0.00367	CcSEcCtD
Prednisone—Abdominal pain—Azathioprine—Crohn's disease	9.38e-05	0.00367	CcSEcCtD
Prednisone—Body temperature increased—Azathioprine—Crohn's disease	9.38e-05	0.00367	CcSEcCtD
Prednisone—Fatigue—Mesalazine—Crohn's disease	9.32e-05	0.00364	CcSEcCtD
Prednisone—Constipation—Mesalazine—Crohn's disease	9.24e-05	0.00361	CcSEcCtD
Prednisone—Feeling abnormal—Mesalazine—Crohn's disease	8.91e-05	0.00348	CcSEcCtD
Prednisone—Gastrointestinal pain—Mesalazine—Crohn's disease	8.84e-05	0.00346	CcSEcCtD
Prednisone—Hypersensitivity—Azathioprine—Crohn's disease	8.74e-05	0.00342	CcSEcCtD
Prednisone—Urticaria—Mesalazine—Crohn's disease	8.59e-05	0.00336	CcSEcCtD
Prednisone—Abdominal pain—Mesalazine—Crohn's disease	8.54e-05	0.00334	CcSEcCtD
Prednisone—Body temperature increased—Mesalazine—Crohn's disease	8.54e-05	0.00334	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.17e-05	0.0279	CbGpPWpGaD
Prednisone—Diarrhoea—Azathioprine—Crohn's disease	8.12e-05	0.00317	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—PPP5C—Crohn's disease	8.06e-05	0.0275	CbGpPWpGaD
Prednisone—Hypersensitivity—Mesalazine—Crohn's disease	7.96e-05	0.00311	CcSEcCtD
Prednisone—Dizziness—Azathioprine—Crohn's disease	7.85e-05	0.00307	CcSEcCtD
Prednisone—SLCO1A2—Transport of organic anions—ALB—Crohn's disease	7.84e-05	0.0267	CbGpPWpGaD
Prednisone—Asthenia—Mesalazine—Crohn's disease	7.76e-05	0.00303	CcSEcCtD
Prednisone—Pruritus—Mesalazine—Crohn's disease	7.65e-05	0.00299	CcSEcCtD
Prednisone—Vomiting—Azathioprine—Crohn's disease	7.55e-05	0.00295	CcSEcCtD
Prednisone—Rash—Azathioprine—Crohn's disease	7.48e-05	0.00293	CcSEcCtD
Prednisone—Dermatitis—Azathioprine—Crohn's disease	7.48e-05	0.00292	CcSEcCtD
Prednisone—Headache—Azathioprine—Crohn's disease	7.43e-05	0.00291	CcSEcCtD
Prednisone—Diarrhoea—Mesalazine—Crohn's disease	7.4e-05	0.00289	CcSEcCtD
Prednisone—Dizziness—Mesalazine—Crohn's disease	7.15e-05	0.00279	CcSEcCtD
Prednisone—Nausea—Azathioprine—Crohn's disease	7.05e-05	0.00276	CcSEcCtD
Prednisone—Vomiting—Mesalazine—Crohn's disease	6.87e-05	0.00269	CcSEcCtD
Prednisone—Rash—Mesalazine—Crohn's disease	6.82e-05	0.00266	CcSEcCtD
Prednisone—Dermatitis—Mesalazine—Crohn's disease	6.81e-05	0.00266	CcSEcCtD
Prednisone—Headache—Mesalazine—Crohn's disease	6.77e-05	0.00265	CcSEcCtD
Prednisone—Nausea—Mesalazine—Crohn's disease	6.42e-05	0.00251	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.37e-05	0.0217	CbGpPWpGaD
Prednisone—ABCB1—lymph node—Crohn's disease	6.35e-05	0.00743	CbGeAlD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.96e-05	0.0203	CbGpPWpGaD
Prednisone—SLCO1A2—Recycling of bile acids and salts—ALB—Crohn's disease	5.81e-05	0.0198	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PLA2G4F—Crohn's disease	4.28e-05	0.0146	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CREM—Crohn's disease	3.93e-05	0.0134	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—MTMR3—Crohn's disease	3.64e-05	0.0124	CbGpPWpGaD
Prednisone—CYP2C19—Arachidonic acid metabolism—GPX4—Crohn's disease	3.33e-05	0.0114	CbGpPWpGaD
Prednisone—SLCO1A2—Bile acid and bile salt metabolism—ALB—Crohn's disease	3.04e-05	0.0104	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	3.01e-05	0.0103	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—GPX4—Crohn's disease	2.97e-05	0.0101	CbGpPWpGaD
Prednisone—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	2.91e-05	0.00992	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—FADS1—Crohn's disease	2.84e-05	0.00967	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—MPO—Crohn's disease	2.79e-05	0.0095	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	2.79e-05	0.0095	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	2.79e-05	0.0095	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—GPX4—Crohn's disease	2.66e-05	0.00906	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—F5—Crohn's disease	2.58e-05	0.0088	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—GCKR—Crohn's disease	2.57e-05	0.00875	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	2.46e-05	0.00838	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	2.36e-05	0.00805	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—MPO—Crohn's disease	2.27e-05	0.00773	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IL10—Crohn's disease	2.21e-05	0.00752	CbGpPWpGaD
Prednisone—NR3C1—Endoderm Differentiation—SMAD3—Crohn's disease	2.17e-05	0.00741	CbGpPWpGaD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	2.12e-05	0.00723	CbGpPWpGaD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—Crohn's disease	2.06e-05	0.00703	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—Crohn's disease	1.96e-05	0.00669	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	1.96e-05	0.00669	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—Crohn's disease	1.89e-05	0.00644	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.83e-05	0.00625	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	1.8e-05	0.00614	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.75e-05	0.00597	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	1.73e-05	0.00592	CbGpPWpGaD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	1.71e-05	0.00583	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	1.67e-05	0.00569	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.6e-05	0.00547	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL17A—Crohn's disease	1.58e-05	0.0054	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—Crohn's disease	1.5e-05	0.00512	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—SOCS1—Crohn's disease	1.5e-05	0.00511	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.49e-05	0.00508	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL12B—Crohn's disease	1.47e-05	0.00502	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	1.47e-05	0.005	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.42e-05	0.00483	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.42e-05	0.00483	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	1.36e-05	0.00464	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	1.36e-05	0.00464	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	1.35e-05	0.00459	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IFNG—Crohn's disease	1.3e-05	0.00442	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—SMAD3—Crohn's disease	1.29e-05	0.00441	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	1.22e-05	0.00417	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—CXCL8—Crohn's disease	1.21e-05	0.00411	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	1.2e-05	0.00408	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—CRP—Crohn's disease	1.19e-05	0.00407	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL10—Crohn's disease	1.16e-05	0.00396	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.16e-05	0.00395	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	1.14e-05	0.0039	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—Crohn's disease	1.14e-05	0.0039	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—ICAM1—Crohn's disease	1.1e-05	0.00374	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.09e-05	0.0037	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL10—Crohn's disease	1.08e-05	0.00367	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—Crohn's disease	1.06e-05	0.00362	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PTRF—Crohn's disease	1.05e-05	0.00359	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	1.02e-05	0.00349	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.97e-06	0.0034	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	9.59e-06	0.00327	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	9.59e-06	0.00327	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	9.47e-06	0.00323	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	9.14e-06	0.00312	CbGpPWpGaD
Prednisone—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	8.96e-06	0.00306	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.82e-06	0.00301	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	8.71e-06	0.00297	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.55e-06	0.00292	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	8.48e-06	0.00289	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IFNG—Crohn's disease	8.34e-06	0.00284	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—ALB—Crohn's disease	8.16e-06	0.00278	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PLA2G4F—Crohn's disease	7.8e-06	0.00266	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.68e-06	0.00262	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL1B—Crohn's disease	7.44e-06	0.00254	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	7.36e-06	0.00251	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.27e-06	0.00248	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PTGS2—Crohn's disease	7.14e-06	0.00244	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.92e-06	0.00236	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.92e-06	0.00236	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	6.86e-06	0.00234	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IL6—Crohn's disease	6.78e-06	0.00231	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	6.76e-06	0.0023	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	6.64e-06	0.00226	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	6.63e-06	0.00226	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—MTMR3—Crohn's disease	6.63e-06	0.00226	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	6.63e-06	0.00226	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—UBE2D1—Crohn's disease	6.61e-06	0.00225	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.53e-06	0.00223	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	6.36e-06	0.00217	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	6.35e-06	0.00217	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IFNG—Crohn's disease	6.33e-06	0.00216	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ZFP36L1—Crohn's disease	6.32e-06	0.00215	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.25e-06	0.00213	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	6.1e-06	0.00208	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.06e-06	0.00207	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.06e-06	0.00207	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	5.97e-06	0.00204	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—STAT3—Crohn's disease	5.91e-06	0.00202	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	5.91e-06	0.00201	CbGpPWpGaD
Prednisone—ALB—Hemostasis—F5—Crohn's disease	5.9e-06	0.00201	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	5.88e-06	0.00201	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.67e-06	0.00193	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL1B—Crohn's disease	5.64e-06	0.00192	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TNF—Crohn's disease	5.4e-06	0.00184	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—DNMT3A—Crohn's disease	5.37e-06	0.00183	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	5.35e-06	0.00183	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.31e-06	0.00181	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—FADS1—Crohn's disease	5.17e-06	0.00176	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—TNF—Crohn's disease	5.12e-06	0.00175	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.09e-06	0.00173	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.87e-06	0.00166	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GPX4—Crohn's disease	4.84e-06	0.00165	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	4.81e-06	0.00164	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.76e-06	0.00162	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—SMAD3—Crohn's disease	4.73e-06	0.00161	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GCKR—Crohn's disease	4.67e-06	0.00159	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—TNF—Crohn's disease	4.42e-06	0.00151	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL6—Crohn's disease	4.36e-06	0.00149	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.31e-06	0.00147	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	4.29e-06	0.00146	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.27e-06	0.00146	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—IL6—Crohn's disease	4.13e-06	0.00141	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—TNF—Crohn's disease	4.1e-06	0.0014	CbGpPWpGaD
Prednisone—ALB—Metabolism—PLA2G4F—Crohn's disease	3.81e-06	0.0013	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.77e-06	0.00129	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—HSPA1B—Crohn's disease	3.63e-06	0.00124	CbGpPWpGaD
Prednisone—ALB—Hemostasis—ITGA4—Crohn's disease	3.63e-06	0.00124	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.57e-06	0.00122	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL3—Crohn's disease	3.54e-06	0.00121	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	3.46e-06	0.00118	CbGpPWpGaD
Prednisone—ALB—Hemostasis—RASGRP1—Crohn's disease	3.42e-06	0.00117	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	3.42e-06	0.00117	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.34e-06	0.00114	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PLA2G4F—Crohn's disease	3.34e-06	0.00114	CbGpPWpGaD
Prednisone—ALB—Metabolism—MTMR3—Crohn's disease	3.24e-06	0.0011	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	3.23e-06	0.0011	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—UBE2D1—Crohn's disease	3.18e-06	0.00108	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.17e-06	0.00108	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.99e-06	0.00102	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.92e-06	0.000996	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—MTMR3—Crohn's disease	2.91e-06	0.000991	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—MTMR3—Crohn's disease	2.84e-06	0.000968	CbGpPWpGaD
Prednisone—ALB—Metabolism—FADS1—Crohn's disease	2.52e-06	0.00086	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2RA—Crohn's disease	2.48e-06	0.000845	CbGpPWpGaD
Prednisone—ALB—Metabolism—GPX4—Crohn's disease	2.36e-06	0.000806	CbGpPWpGaD
Prednisone—ALB—Metabolism—GCKR—Crohn's disease	2.28e-06	0.000778	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—SMAD3—Crohn's disease	2.28e-06	0.000776	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—FADS1—Crohn's disease	2.27e-06	0.000772	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—FADS1—Crohn's disease	2.21e-06	0.000754	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GPX4—Crohn's disease	2.12e-06	0.000723	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GPX4—Crohn's disease	2.07e-06	0.000706	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.06e-06	0.000701	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GCKR—Crohn's disease	2.05e-06	0.000699	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.02e-06	0.000689	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GCKR—Crohn's disease	2e-06	0.000682	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.75e-06	0.000596	CbGpPWpGaD
Prednisone—ALB—Hemostasis—JAK2—Crohn's disease	1.67e-06	0.000568	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ALB—Crohn's disease	1.49e-06	0.000507	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.46e-06	0.000499	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.43e-06	0.000486	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—FADS1—Crohn's disease	1.36e-06	0.000464	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.36e-06	0.000463	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—Crohn's disease	1.3e-06	0.000443	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.28e-06	0.000437	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GPX4—Crohn's disease	1.28e-06	0.000435	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GCKR—Crohn's disease	1.23e-06	0.00042	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALB—Crohn's disease	6.52e-07	0.000222	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALB—Crohn's disease	6.36e-07	0.000217	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—Crohn's disease	6.35e-07	0.000217	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—Crohn's disease	5.7e-07	0.000194	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—Crohn's disease	5.57e-07	0.00019	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALB—Crohn's disease	3.92e-07	0.000134	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.43e-07	0.000117	CbGpPWpGaD
